Clinical Trial Update: A Single-dose Study to Investigate the Effects of 4 Different Doses of Inhaled AZD8683 in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 2]

View source ↗

Summary

This update covers a Phase 2, single-dose inhaled study of four AZD8683 dose levels in patients with Chronic Obstructive Pulmonary Disease. The trial was termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• AZD8683

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease, COPD | Phase 2 | Status: TERMINATED | Results posted: 2013-09-30